Spiral vaso-occlusion coil

Description

FIG. 1 is a perspective view of a first embodiment of the spiral vaso-occlusion coil embodying my design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a right side view thereof;

FIG. 4 is a left side view thereof;

FIG. 5 is a front view thereof;

FIG. 6 is a rear view thereof;

FIG. 7 is a bottom view thereof;

FIG. 8 is a perspective view of a second embodiment of the spiral vaso-occlusion coil embodying my design;

FIG. 9 is a top plan view thereof;

FIG. 10 is a right side view thereof;

FIG. 11 is a left side view thereof;

FIG. 12 is a front view thereof;

FIG. 13 is a rear view thereof;

FIG. 14 is a bottom view thereof;

FIG. 15 is a perspective view of a third embodiment of the spiral vaso-occlusion coil embodying my design;

FIG. 16 is a top plan view thereof;

FIG. 17 is a right side view thereof;

FIG. 18 is a left side view thereof;

FIG. 19 is a front view thereof;

FIG. 20 is a rear view thereof; and,

FIG. 21 is a bottom view thereof.

Claims

The ornamental design for a spiral vaso-occlusion coil, as shown and described.

---

Inventors:	Mariant; Michael (San Jose, CA), Palermo; Thomas J. (Mountain View, CA)
Assignee:	Target Therapeutics, Inc. (Fremont, CA)
Appl. No.:	D/037,001
Filed:	March 31, 1995

---

Current U.S. Class:	D24/143; D24/155
Current International Class:	2402
Field of Search:	;D24/155,143 ;606/151,157,198,194,195,200,191,192

---

References Cited [Referenced By]

---

U.S. Patent Documents

4820298	April 1989	Leveen et al.
4994069	February 1991	Ritchart et al.
5197978	March 1993	Hess
5226911	July 1993	Chee et al.
5304194	April 1994	Chee et al.
5334210	August 1994	Gianturco
5382259	January 1995	Phelps et al.
5413560	May 1995	Solar
5476472	December 1995	Dormand, Jr. et al.

Foreign Patent Documents

	WO 95/25480		Sep 1995		WO

Other References

Domestic Product Catalog, Target Therapeutics.RTM., Target Therapeutics, Inc., 47201 Lakeview Blvd., Fremont, CA 94537-5120, 4 pages total, Apr. 1995..

Primary Examiner: Clark; Doris
Attorney, Agent or Firm: Morrison & Foerster LLP